Filter results by
Search HelpCurrently selected filters that can be removed
Remove Remove "Province or territory" filterRemove Remove "Occasional" filterRemove Remove "Canadian COVID-19 Antibody and Health Survey (CCAHS)" filter
Keyword(s)
Geography
3 facets displayed. 1 facets selected.
Survey or statistical program
1 facets displayed. 1 facets selected.
Results
All (3)
All (3) ((3 results))
- Table: 13-10-0868-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.Release date: 2023-08-03
- Table: 13-10-0866-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.Release date: 2023-03-27
- 3. SARS-CoV-2 antibody seroprevalence in Canadians, by age group and sex, November 2020 to April 2021Table: 13-10-0818-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription:
Seroprevalence of Canadians aged 1 and older with antibodies against SARS-CoV-2 (the virus that causes COVID-19), overall and by antibody type, by age group and sex.
Release date: 2021-07-06
Tables (3)
Tables (3) ((3 results))
- Table: 13-10-0868-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.Release date: 2023-08-03
- Table: 13-10-0866-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.Release date: 2023-03-27
- 3. SARS-CoV-2 antibody seroprevalence in Canadians, by age group and sex, November 2020 to April 2021Table: 13-10-0818-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription:
Seroprevalence of Canadians aged 1 and older with antibodies against SARS-CoV-2 (the virus that causes COVID-19), overall and by antibody type, by age group and sex.
Release date: 2021-07-06
Profiles of a community or region (0)
Profiles of a community or region (0) (0 results)
No content available at this time.
Thematic maps (0)
Thematic maps (0) (0 results)
No content available at this time.
Public use microdata (0)
Public use microdata (0) (0 results)
No content available at this time.
Data Visualization (0)
Data Visualization (0) (0 results)
No content available at this time.
- Date modified: